Catalyst Wire Dossier Catalyst Wire Dossier

Nepafenac 0.1%

nepafenac · Alcon
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nepafenac 0.1%, covering 2018-04-04 to 2018-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections [NA]

See pricing